Posted by Michael Wonder on 08 Nov 2021
EMA publishes agenda for 8-11 November CHMP meeting
8 November 2021 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Bevacizumab
- Finerenone
- Sotorasib
- Regdanvimab
- Budesomide with eformoterol fumarate dihydrate and glycopyrronium bromide
- Avacopan
- Tecviromat
- Glucarpidase
- Eptinezumab
- Semaglutide
